Cohance Lifesciences Ltd (COHANCE) — Announcement | 17 September 2026

17 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

💡 Investor Takeaway

Investors can expect increased engagement with global analysts and potential insights into growth plans.

Cohance Lifesciences Ltd announced it will attend the JP Morgan India Conference in Mumbai on 22 September 2026 and a JP Morgan Roadshow in Hyderabad on 24 September 2026, offering analysts and institutional investors group and one-on-one meetings. The company emphasized no unpublished price-sensitive information will be shared during these interactions. This investor outreach aims to enhance market visibility and provide deeper insights into its operations and growth strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — COHANCE ✨ Ask AI About This

About Cohance Lifesciences Ltd (COHANCE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹17,473.75 CrP/E: 298.5ROE: 2.7%ROCE: 3.3%

View full COHANCE stock details →

📡 Get AI alerts when COHANCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track COHANCE — Free

💡 Ask AI about this filing

"How will participation in JP Morgan conferences impact COHANCE's valuation?""What growth metrics will management highlight during investor meetings?""Are there upcoming product launches or regulatory approvals expected?"

Ask AI Free →

📊 More COHANCE filings

Announcement — 28 September 2026Cohance Lifesciences Ltd announced that its trading window closes on 1 October 2026 for insiders and...
Announcement — 21 September 2026Cohance Lifesciences announced that the USFDA inspected its API facility in Andhra Pradesh from Sept...
🟡 Board Meeting — 18 September 2026Cohance Lifesciences invested USD 10 million in newly issued Compulsorily Convertible Preferred Stoc...
🔴 Announcement — 5 September 2026Cohance Lifesciences announced that the USFDA completed an inspection of its formulation plant in Sh...
🟡 Board Meeting — 3 September 2026Cohance Lifesciences announced a strategic reorganisation involving two key transactions: acquiring ...

See all COHANCE filings →

🔥 Also filed on 17 September 2026

EICHERMOTEicher Motors LtdAnnouncement SGMARTSG Mart LtdAnnouncement NEOGENNeogen Chemicals LtdCorporate Action BRAHMINFRABrahmaputra Infrastructure LtdAnnouncement PVPPVP Ventures LtdCorporate Action SONACOMSSona BLW Precision Forgings LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when COHANCE files new disclosures

Track COHANCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.